[go: up one dir, main page]

WO2008129517A3 - A stabilized delayed release pharmaceutical composition of rabeprazole - Google Patents

A stabilized delayed release pharmaceutical composition of rabeprazole Download PDF

Info

Publication number
WO2008129517A3
WO2008129517A3 PCT/IB2008/051568 IB2008051568W WO2008129517A3 WO 2008129517 A3 WO2008129517 A3 WO 2008129517A3 IB 2008051568 W IB2008051568 W IB 2008051568W WO 2008129517 A3 WO2008129517 A3 WO 2008129517A3
Authority
WO
WIPO (PCT)
Prior art keywords
rabeprazole
stabilized
pharmaceutical composition
delayed release
release pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2008/051568
Other languages
French (fr)
Other versions
WO2008129517A2 (en
Inventor
Chayapathy Issa
Puneet Mangat
Rajesh Gandhi
Romi Barat Singh
Rajeev Shanker Mathur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of WO2008129517A2 publication Critical patent/WO2008129517A2/en
Publication of WO2008129517A3 publication Critical patent/WO2008129517A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a stabilized delayed release pharmaceutical composition of rabeprazole comprising: a. a tablet core comprising rabeprazole or pharmaceutically acceptable salt thereof, sodium carbonate and a. disintegrant selected from the group consisting of crospovidone and low substituted hydroxypropylcelullose; b. a seal coating comprising ethyl cellulose and a disintegrant selected from the group consisting of crospovidone and low substituted hydroxypropylcelullose; and c. an enteric coating.
PCT/IB2008/051568 2007-04-23 2008-04-24 A stabilized delayed release pharmaceutical composition of rabeprazole Ceased WO2008129517A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN892DE2007 2007-04-23
IN892/DEL/2007 2007-04-23
IN2046DE2007 2007-09-27
IN2046/DEL/2007 2007-09-27

Publications (2)

Publication Number Publication Date
WO2008129517A2 WO2008129517A2 (en) 2008-10-30
WO2008129517A3 true WO2008129517A3 (en) 2009-05-07

Family

ID=39651210

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2008/051568 Ceased WO2008129517A2 (en) 2007-04-23 2008-04-24 A stabilized delayed release pharmaceutical composition of rabeprazole

Country Status (1)

Country Link
WO (1) WO2008129517A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010078399A2 (en) 2008-12-31 2010-07-08 3M Innovative Properties Company Sampling devices and methods for concentrating microorganisms
CN102325596B (en) 2008-12-31 2015-04-29 3M创新有限公司 Live Bioburden Detection Using Microparticles
US9284593B2 (en) 2009-12-30 2016-03-15 3M Innovative Properties Company Live bioload detection using microparticles
WO2011082258A2 (en) 2009-12-30 2011-07-07 Regents Of The University Of Minnesota Bone cement and method
GB201003734D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Delayed prolonged drug delivery
GB201003731D0 (en) * 2010-03-05 2010-04-21 Univ Strathclyde Immediate/delayed drug delivery
GB201003766D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Pulsatile drug release
CN103784414B (en) * 2013-12-18 2018-01-30 北京华禧联合科技发展有限公司 A kind of esomeprazole enteric coatel tablets and preparation method thereof
CN105287425A (en) * 2015-10-29 2016-02-03 沈阳药大制剂新技术有限公司 Stable rabeprazole sodium enteric-coated tablets and preparation method
CN105640915A (en) * 2016-03-02 2016-06-08 吉林修正药业新药开发有限公司 Rebeprazole sodium enteric-coated tablet and preparation process thereof
CN111281855B (en) * 2020-03-23 2021-09-24 乐普制药科技有限公司 Rabeprazole enteric-coated tablet and preparation method thereof
CN119345145A (en) * 2024-12-20 2025-01-24 山东百诺医药股份有限公司 Ilaprazole enteric-coated tablets and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004305A1 (en) * 1998-04-20 2000-05-31 Eisai Co., Ltd. Stabilized compositions containing benzimidazole-type compounds
EP1222922A1 (en) * 1999-10-20 2002-07-17 Eisai Co., Ltd. Method for stabilizing benzimidazole compounds
US20040146558A1 (en) * 2003-01-28 2004-07-29 Kyowa Pharmaceutical Co., Ltd. Oral enteric-coated preparation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004305A1 (en) * 1998-04-20 2000-05-31 Eisai Co., Ltd. Stabilized compositions containing benzimidazole-type compounds
EP1222922A1 (en) * 1999-10-20 2002-07-17 Eisai Co., Ltd. Method for stabilizing benzimidazole compounds
US20040146558A1 (en) * 2003-01-28 2004-07-29 Kyowa Pharmaceutical Co., Ltd. Oral enteric-coated preparation

Also Published As

Publication number Publication date
WO2008129517A2 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
WO2008129517A3 (en) A stabilized delayed release pharmaceutical composition of rabeprazole
WO2006011159A3 (en) Stabilized pharmaceutical composition containing rabeprazole sodium with improved bioavailability
WO2007139886A3 (en) Duloxetine hydrochloride delayed release formulations
WO2009066315A3 (en) Sustained release compositions of trimetazidine and process for preparation thereof
WO2004062577A3 (en) Two or more enteric materials to regulate drug release
WO2011002857A3 (en) 3-cyanoquinoline tablet formulations and uses thereof
WO2010070449A3 (en) Highly pure laquinimod or a pharmaceutically acceptable salt thereof
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2010049449A3 (en) Novel salts of sunitinib
WO2010144339A3 (en) A thrombin receptor antagonist and clopidogrel fixed dose tablet
WO2010046932A3 (en) Extended release pharmaceutical composition of minocycline and process thereof
WO2007110753A3 (en) Extended release dosage forms of metoprolol
WO2010006904A3 (en) Crystalline forms of rabeprazole sodium
WO2008049922A3 (en) A new process for the preparation of montelukast
WO2010018175A3 (en) Oral pharmaceutical formulation for omeprazole comprising a specific separation layer
WO2010137040A3 (en) Novel pharmaceutical compositions of ranolazine
WO2011064797A3 (en) Controlled release pharmaceutical compositions of galantamine
WO2009150238A3 (en) Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives
WO2009087657A3 (en) Stable pharmaceutical composition of duloxetine and process for its preparation
WO2008039894A3 (en) Atorvastatin pharmaceutical compositions
WO2008000463A3 (en) Rabeprazole formulation
WO2009013594A3 (en) Process for the preparation of controlled-release solid formulations containing oxcarbazepine, and formulations obtainable by said process
WO2011107921A3 (en) Modified release composition of milnacipran
WO2009066181A3 (en) Oral delayed-release duloxentine hydrochloride pellets
EP2575457A4 (en) Oral pharmaceutical composition of duloxetine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08737972

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08737972

Country of ref document: EP

Kind code of ref document: A2